Radboud university medical center
Radboudumc is a Dutch public academic medical center in Nijmegen (13,000 staff, ~30K inpatients and 400K outpatients yearly), providing tertiary care, pediatric medicine via the Amalia Children's Hospital, and clinical long-read genome sequencing for rare diseases.
- Company typePublic
- Founded1951
- HeadquartersNijmegen, Netherlands
- Headcount5,001–10,000
- GTM typeB2C
- OfferingServices
What Radboud university medical center does
Radboud university medical center (Radboudumc) is a public academic medical center in Nijmegen, Netherlands, founded in 1951 and affiliated with Radboud University on a joint campus. The center operates a tertiary care hospital together with the Amalia Children's Hospital (one of eight academic children's hospitals in the Netherlands), serving approximately 30,000 inpatients and 400,000 outpatients annually. Radboudumc is staffed by 13,000 employees across clinical, research, and educational roles.
The institution generates revenue primarily through regulated Dutch Diagnosis Treatment Combinations (DBCs) billed under the national health insurance framework, supplemented by research grants and competitive funding (Leducq, EU, patient foundations). Its go-to-market is sales-led via referrals from general practitioners and regional hospitals, with research-driven acquisition through collaborations with Dutch university medical centers (notably Maastricht UMC+) and international consortia. Customer segments include patients with rare genetic disorders (the core focus for its long-read sequencing program), pediatric patients and families, infectious disease cases, and tertiary referral patients from across the Netherlands.
Radboudumc's most differentiated technology is clinical-grade long-read genome sequencing, the first deployment at scale worldwide. The test reads up to 20,000 base pairs (vs. ~300 in standard sequencing), can replace up to 15 separate genetic tests in a single assay, simultaneously detects epigenetic modifications, and yields a 3% increase in diagnostic rate for rare diseases (validated in 1,000 patients and published in the New England Journal of Medicine). The center plans to perform ~5,000 long-read tests annually, roughly one-sixth of its total annual diagnostic volume. Additional specialty capabilities include continuous remimazolam sedation for endoscopy, bionic foot development with University of Twente, 3D-printed prosthetics in The Gambia, and extramural astrobiology research with the German Aerospace Center.
Radboud university medical center firmographics
Firmographics- Name
- Radboud university medical center
- Legal name
- Radboud university medical center
- Website
- https://radboudumc.nl
- Company type
- Public
- Founded year
- 1951
- Operating status
- Operating
- Headcount range
- 5,001–10,000 employees
- Short description
- Radboudumc is a Dutch public academic medical center in Nijmegen (13,000 staff, ~30K inpatients and 400K outpatients yearly), providing tertiary care, pediatric medicine via the Amalia Children's Hospital, and clinical long-read genome sequencing for rare diseases.
- Ownership category
- akta.pro rank
Radboud university medical center industry classification
Industry- Product category
- Academic Medical Center
- NAICS
- General Medical and Surgical Hospitals (622110), General Medical and Surgical Hospitals (62211), Medical Laboratories (621511), Specialty (except Psychiatric and Substance Abuse) Hospitals (622310)
- SIC
- Services-Hospitals (8060), Services-General Medical & Surgical Hospitals, Nec (8062), Services-Medical Laboratories (8071)
- akta.pro primary industry
- Community & Regional General Hospitals (HLAFAAAB)
- akta.pro secondary industries
- Clinical Research & Trial Central Laboratories (HLAFAMAL), Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI)
Keywords
Where Radboud university medical center is headquartered
LocationHeadquarters
- HQ city
- Nijmegen
- HQ country
- Netherlands
- HQ region
- Europe
Offices1 record
Markets served
Radboud university medical center business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Technology or R&D, Others
Revenue model
- Healthcare service delivery: University medical center providing comprehensive healthcare services to patients. Revenue generated through Diagnosis Treatment Combinations (DBCs) under Dutch healthcare insurance system. Patient volumes include approximately 30,000 inpatients and 400,000 outpatients annually.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Multi-year contract | Public healthcare services covered by Dutch health insurance |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels6 records
Radboud university medical center product offering
Product offeringCore offering
Radboud university medical center (Radboudumc) is a Dutch university medical center in Nijmegen delivering patient healthcare, biomedical research, and medical education. It treats approximately 30,000 inpatients and 400,000 outpatients annually and operates 665 beds across specialized care areas, including the Amalia Children's Hospital and clinical genetics.
Product overview
Radboud university medical center (Radboudumc) is an academic medical center in Nijmegen, Netherlands, offering integrated healthcare services, research, and education. The center provides patient care across multiple specialties including the Amalia Children's Hospital, conducts scientific research across various disciplines (such as genetics, genomics, pediatrics, infectious diseases, and biomedical technology), and offers academic training programs for students and researchers. The center collaborates with Radboud University on a joint campus.
Differentiator
Problem solved
Functional benefit
Brands
- Amalia Kinderziekenhuis: The Amalia Children's Hospital provides medical care for children and pregnant women, operating as a specialized children's hospital within Radboudumc.
Quantifiable outcome
- 3% increase in diagnostic yield for rare genetic disorders
- +3 more outcomes
Companies that use Radboud university medical center
Customer profileNamed customers5 records
Segments4 records
Ideal customer profiles3 records
Radboud university medical center technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Radboud university medical center partnerships and signals
Strategic signalPartnerships
Twelve partnerships are on record, tiered core and minor.
- Medical Research Council Unit The GambiacorePartnership in 3D printing pilot program for prosthetic socket production. Co-financed by European Union, implemented with technical support from University of Southampton and 3D Lab at Radboud UMC.
- National Rehabilitation Centre The GambiaminorImplementation partner for 3D printing prosthetic socket project in The Gambia, replacing traditional socket-making methods.
- FSHD EuropecorePatient organization partnership for PaLaDIn project, creating patient-focused platform collecting data directly from patients with neuromuscular disorders. Linked to Radboudumc and partner in Project Mercury.
- Parent Project ItalycoreLead organization of PaLaDIn consortium with international scope, with FSHD case study workstream co-led by FSHD Society and TREAT-NMD.
- FSHD SocietycoreCo-leader of FSHD case study workstream within PaLaDIn project, part of Project Mercury global patient-led initiative.
- TREAT-NMDcoreUK-based organization co-leading FSHD case study workstream within PaLaDIn project, supported by global network of neuromuscular field experts.
- Boston UniversitycoreLead coordination of international research project TRAFFIC on cerebral amyloid angiopathy (CAA), funded by $9M Leducq Foundation grant. Network includes researchers from multiple US and European institutions combining brain imaging, laboratory research, and patient data.
- German Aerospace Center (DLR)minorResearch collaboration investigating whether terrestrial microorganisms can survive in extraterrestrial conditions on Moon, Mars, and icy moons of Jupiter and Saturn.
- Radboud UniversitycoreCollaboration on choroideremia research as part of Radboud University and Radboudumc partnership, pursuing gene therapy and antisense oligonucleotides approaches.
- University of TwenteminorJoint development of bionic foot that mimics natural walking, supported by European SimBionics project with integrated sensors and battery for real-life testing.
- Maastricht University Medical CenterminorInitial research partner for TACTICAS pilot study on COPD exacerbation detection through voice recordings, with Radboudumc now collaborating on SPEAK mobile app development.
- Maastricht UMC+coreCollaborative partnership for long-read genome sequencing research and clinical implementation. Jointly developing and validating new genetic diagnostic tests for rare diseases. Research validated across 1,000 patients and published in New England Journal of Medicine.
Scale indicators5 records
Recent moves7 records
Expansion highlights7 records
Radboud university medical center competitors and assessment
Company assessmentDirect peers
- Erasmus MC: Rotterdam-based Dutch university medical center with comparable scale (~14,000 staff), research/teaching mission, and a similar academic-hospital operating model serving as a direct domestic peer within the eight-center NFU consortium.
- Amsterdam UMC: Merged AMC-VUmc Dutch university medical center with similar academic mission, multi-specialty clinical services, research output, and government-funded teaching hospital structure as Radboudumc.
- UMC Utrecht: Dutch university medical center sharing the same NFU academic-hospital classification, research-teaching-care integrated model, and pediatric and rare-disease programs comparable to Radboudumc.
- Maastricht UMC+: Dutch academic medical center and current strategic partner on the long-read genome sequencing program, providing a directly comparable model for clinical-academic integration and rare-disease diagnostics.
- Leiden University Medical Center (LUMC): Dutch university medical center with comparable academic hospital structure, rare-disease expertise, and NFU membership, serving a comparable patient population in western Netherlands.
- University Medical Center Groningen (UMCG): Northern Dutch academic medical center with similar scale, academic mission, and tertiary referral role; shares the Dutch UMC operating model and DBC reimbursement system with Radboudumc.
Broad incumbents
- Karolinska University Hospital: Swedish university hospital with comparable academic-medical-center mission, rare-disease and genomics programs, and Nordic public funding model — broader in geographic reach and research output than Radboudumc.
- Mayo Clinic: Largest US academic medical center with integrated research-clinical-education model, rare-disease diagnostics, and genomics leadership — broader in scale and global brand but a structurally analogous academic medical institution.
- Cleveland Clinic: US-based academic medical system with comparable tertiary referral base, research output, and specialty-care positioning — broader and more globally recognized but serving the same academic-clinical integrated function.
Others
- Pacific Biosciences: Provider of the HiFi long-read sequencing platform underpinning Radboudumc's rare-disease diagnostic program; while not a clinical peer, it is the core technology enabler for the institution's flagship clinical innovation.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Radboud university medical center social profiles
Digital presenceRadboud university medical center financial estimates
Financial estimateRevenue estimate
Valuation estimate
Radboud university medical center leadership team
Management profileNumber of profiles
Profiles3 records
Radboud university medical center funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Radboud university medical center M&A and investment
M&A and investmentM&A
Investments1 record
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Radboud university medical center
What does Radboud university medical center do?
Radboud university medical center (Radboudumc) is a Dutch university medical center in Nijmegen delivering patient healthcare, biomedical research, and medical education. It treats approximately 30,000 inpatients and 400,000 outpatients annually and operates 665 beds across specialized care areas, including the Amalia Children's Hospital and clinical genetics.
Is Radboud university medical center a public or private company?
Radboud university medical center is a public company. It is classified as state government owned and is currently operating.
When was Radboud university medical center founded?
Radboud university medical center was founded in 1951. It employs 5,001 to 10,000 people.
Where is Radboud university medical center based?
Radboud university medical center is headquartered in Nijmegen, Netherlands, in the Europe region.
How does Radboud university medical center make money?
One revenue line is on record: healthcare service delivery.
Who are Radboud university medical center's main competitors?
Direct peers on record are Erasmus MC, Amsterdam UMC, UMC Utrecht, Maastricht UMC+, Leiden University Medical Center (LUMC) and University Medical Center Groningen (UMCG). Broad incumbents are Karolinska University Hospital, Mayo Clinic and Cleveland Clinic. Pacific Biosciences is listed as an others.
Does Radboud university medical center have an API?
No public API is recorded for Radboud university medical center.
What industry is Radboud university medical center in?
Radboud university medical center's product category is Academic Medical Center. Its primary akta.pro industry code is HLAFAAAB, Community & Regional General Hospitals, with a secondary code of HLAFAMAL, Clinical Research & Trial Central Laboratories. Its NAICS code is 622110 and its SIC code is 8060.